Furthermore, treatment with dexamethasone, a synthetic glucocorticoid that has been shown to upregulate HER2 expression in Ishikawa endometrial cancer cells [24], also overrides the disruptive effects of arecoline on ZO-1 localization. This evidence concerns the gene ERBB2 and endometrial cancer.